VectorY
VectorY is an integrated gene therapy company focused on development of therapeutics for CNS, somatic disorders and muscle diseases.
Operating in biotechnology based in European Union (EU), Europe, Middle East, and Africa (EMEA), VectorY was founded in 2020.
VectorY is positioned in biotechnology, a segment that rewards a clear, focused offering.
European Union (EU), Europe, Middle East, and Africa (EMEA) is where the company is located.
Directory data places it at the Series_A stage.
The company reports a headcount in the c_00051_00100 range.
It has disclosed roughly $160M in funding.
| Sector | Biotechnology |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2020 |
| Employees | c_00051_00100 |
| Stage | series_a |
| Total funding | $160,000,000 |
Website: www.vectorytx.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account